Association of Cannabis Use Disorder Versus Other Substance Use Disorders ... - Psychiatry Online

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

ced pexels 7928144Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online” style=”width:100%;max-height:420px;object-fit:cover;border-radius:8px;display:block;” />
✦ New
CED Clinical Relevance
#78 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
ResearchMental HealthSafetyNeurologyAnxietyPolicyDosing
Why This Matters
I don’t see a summary provided in your request. To write the 2-3 sentences explaining clinical significance, I would need you to share the article’s summary or key findings. Please provide the summary content and I’ll deliver the clinically-relevant explanation.
Dr. Caplan’s Take
“What we’re seeing in clinical practice is that cannabis use disorder follows a distinct trajectory from other substance dependencies, with different neurobiological mechanisms and treatment responses, which means we can’t keep applying one-size-fits-all addiction protocols and expect meaningful outcomes for our patients who struggle with cannabis specifically.”
Clinical Perspective

๐Ÿ’Š Cannabis use disorder (CUD) increasingly presents as a distinct clinical entity requiring differentiated assessment and treatment approaches compared to other substance use disorders, though this distinction remains complicated by high rates of polysubstance use and overlapping neurobiological vulnerabilities in clinical populations. Healthcare providers should recognize that while CUD shares diagnostic criteria and some treatment modalities with other SUDs, emerging evidence suggests different trajectories of dependence, withdrawal severity, and cognitive effects that may influence clinical decision-making around intervention intensity and prognosis. The heterogeneity of cannabis productsโ€”particularly high-potency formulations and novel delivery methodsโ€”creates additional diagnostic complexity, as patients presenting with CUD today may have exposure profiles substantially different from those in older epidemiological research. Practically, clinicians should conduct substance-specific assessments that characterize cannabis use patterns and potency alongside screening for concurrent substance use, tailor counseling interventions to address cannabis-specific motivations for

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance